FDA Clearance Tracker · P950014-S021
PROSTATRON (TM) SYSTEM DISPOSABLE TREATMENT APPLICATOR
Last checked: Nov 20, 2026Latest source record: Sep 19, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Sep 19, 2001
Approved
Time to decision
79 days
Received Jul 2, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P950014-S021
- Device name
- PROSTATRON (TM) SYSTEM DISPOSABLE TREATMENT APPLICATOR
- Applicant
- Urologix, Inc.
- Applicant location
- Plymouth, MN
- Received
- Jul 2, 2001
- Decided
- Sep 19, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P950014
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A NEW MANUFACTURING SITE LOCATED AT VENUSA DE MEXICO S.A. DE C.V, CHIHUAHUA, MEXICO, IN WHICH THE PROSTATRON DISPOSABLE TREATMENT APPLICATOR WILL BE ASSEMBLED. IN ADDITION, APPROVAL FOR A MANUFACTURING FACILITY LOCATED AT VENUSA LTD., EL PASO, TEXAS, FOR THE RECEIPT, INSPECTION, STORAGE, AND RELEASE OF COMPONENTS AND THE QUARANTINE OF FINISHED STERILIZED DEVICES. ALSO, THE APPLICATOR WILL BE STERILIZED AT GRIFFITH MICROSCIENCE, SANTA TERESA, NEW MEXICO.
Source documents
Other decisions for Urologix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K142248 · Decided Feb 20, 2015 · 190 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.